CCL2 and breast cancer: The majority of studies have linked this chemokine with malignant processes including lymphatic metastasis63, angiogenesis64, and epithelial-mesenchymal transition65, and tumor cell CCL2 expression has been identified as an independent predictor of negative BC patient prognostic outcomes66.